TY - JOUR
T1 - The Impact of Human Immunodeficiency Virus Infection on Gut Microbiota α-Diversity
T2 - An Individual-level Meta-analysis
AU - Tuddenham, Susan A.
AU - Koay, Wei Li A.
AU - Zhao, Ni
AU - White, James R.
AU - Ghanem, Khalil G.
AU - Sears, Cynthia L.
AU - Dillon, Stephanie
AU - Wilson, Cara
AU - Lozupone, Catherine
AU - Ward, Honorine
AU - Wanke, Christine
AU - Dubourg, Gregory
AU - Raoult, Didier
AU - Palmer, Brent
AU - Monaco, Cynthia
AU - Kwon, Douglas
AU - Mutlu, Ece
AU - Landay, Alan
AU - Paredes, Roger
AU - Noguera-Julian, Marc
AU - Sönnerborg, Anders
AU - Neogi, Ujjwal
AU - Nowak, Rebecca
AU - Ravel, Jacques
AU - Pérez-Santiago, Josué
AU - Smith, Davey M.
AU - Pinto-Cardoso, Sandra
AU - Reyes-Terán, Gustavo
AU - Serrano-Villar, Sergio
AU - Gosalbes Soler, Maria Jose
AU - Vesterbacka, Jan
AU - Nowak, Piotr
AU - Pérez-Matute, P.
AU - Oteo, José A.
AU - D'Auria, Giuseppe
AU - Villar-García, Judit
AU - Yu, Guoqin
AU - Goedert, James J.
N1 - Funding Information:
Potential conflicts of interest. J. R. W. discloses ownership of Resphera Biosciences. C. L. S. has received research funding from Bristol-Myers Squibb for studies on the microbiome and cancer therapy. S. S. V. has received grants and personal fees from Gilead and MSD, and personal fees from Janssen. All other authors report no potential conflicts of interest. All authors have submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Conflicts that the editors consider relevant to the content of the manuscript have been disclosed.
Funding Information:
Financial support. This publication resulted from research supported by a Willowcroft Foundation grant (to S. T.) and by the Johns Hopkins University Center for AIDS Research, a NIH-funded program (P30AI094189), which is supported by the following NIH cofunding and participating institutes and centers: National Institute of Allergy and Infectious Diseases, National Cancer Institute, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Heart, Lung, and Blood Institute, National Institute on Drug Abuse, National Institute of Mental Health, National Institute on Aging, Fogarty International Center, National Institute of General Medical Sciences, National Institute of Diabetes and Digestive and Kidney Diseases, and Office of AIDS Research. S. T. and W. K. are supported by the NIH (award numbers K23AI125715 and T32AI052071, respectively).
Publisher Copyright:
© 2019 The Author(s) 2019. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com.
PY - 2020/2/3
Y1 - 2020/2/3
N2 - Background: Whether human immunodeficiency virus (HIV) infection impacts gut microbial α-diversity is controversial. We reanalyzed raw 16S ribosomal RNA (rRNA) gene sequences and metadata from published studies to examine α-diversity measures between HIV-uninfected (HIV-) and HIV-infected (HIV+) individuals. Methods: We conducted a systematic review and individual level meta-analysis by searching Embase, Medline, and Scopus for original research studies (inception to 31 December 2017). Included studies reported 16S rRNA gene sequences of fecal samples from HIV+ patients. Raw sequence reads and metadata were obtained from public databases or from study authors. Raw reads were processed through standardized pipelines with use of a high-resolution taxonomic classifier. The χ2 test, paired t tests, and generalized linear mixed models were used to relate α-diversity measures and clinical metadata. Results: Twenty-two studies were identified with 17 datasets available for analysis, yielding 1032 samples (311 HIV-, 721 HIV+). HIV status was associated with a decrease in measures of α-diversity (P <. 001). However, in stratified analysis, HIV status was associated with decreased α-diversity only in women and in men who have sex with women (MSW) but not in men who have sex with men (MSM). In analyses limited to women and MSW, controlling for HIV status, women displayed increased α-diversity compared with MSW. Conclusions: Our study suggests that HIV status, sexual risk category, and gender impact gut microbial community α-diversity. Future studies should consider MSM status in gut microbiome analyses.
AB - Background: Whether human immunodeficiency virus (HIV) infection impacts gut microbial α-diversity is controversial. We reanalyzed raw 16S ribosomal RNA (rRNA) gene sequences and metadata from published studies to examine α-diversity measures between HIV-uninfected (HIV-) and HIV-infected (HIV+) individuals. Methods: We conducted a systematic review and individual level meta-analysis by searching Embase, Medline, and Scopus for original research studies (inception to 31 December 2017). Included studies reported 16S rRNA gene sequences of fecal samples from HIV+ patients. Raw sequence reads and metadata were obtained from public databases or from study authors. Raw reads were processed through standardized pipelines with use of a high-resolution taxonomic classifier. The χ2 test, paired t tests, and generalized linear mixed models were used to relate α-diversity measures and clinical metadata. Results: Twenty-two studies were identified with 17 datasets available for analysis, yielding 1032 samples (311 HIV-, 721 HIV+). HIV status was associated with a decrease in measures of α-diversity (P <. 001). However, in stratified analysis, HIV status was associated with decreased α-diversity only in women and in men who have sex with women (MSW) but not in men who have sex with men (MSM). In analyses limited to women and MSW, controlling for HIV status, women displayed increased α-diversity compared with MSW. Conclusions: Our study suggests that HIV status, sexual risk category, and gender impact gut microbial community α-diversity. Future studies should consider MSM status in gut microbiome analyses.
KW - AIDS
KW - HIV
KW - microbiome
UR - http://www.scopus.com/inward/record.url?scp=85078867074&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85078867074&partnerID=8YFLogxK
U2 - 10.1093/cid/ciz258
DO - 10.1093/cid/ciz258
M3 - Article
C2 - 30921452
AN - SCOPUS:85078867074
SN - 1058-4838
VL - 70
SP - 615
EP - 627
JO - Clinical Infectious Diseases
JF - Clinical Infectious Diseases
IS - 4
ER -